Email to a Colleague
Medscape Conference Coverage, based on selected sessions at the:
Associated Professional Sleep Societies 19th Annual Meeting
June 18 - 23, 2005, Denver, Colorado

This activity is not sanctioned by, nor a part of, the Associated Professional Sleep Societies.


Topic Overviews
Highlights of the Associated Professional Sleep Societies 19th Annual Meeting CME/CE
Physicians - up to 1.0 hour(s) of AMA PRA category 1 credit;
Registered Nurses - up to 1.2 Nursing Continuing Education contact hour(s)
Advances in Understanding the Nature of Insomnia
Thomas Roth, PhD
Pharmacologic Advances in the Treatment of Insomnia
Wallace Mendelson, MD
Advances in Understanding and Treating Sleep Apnea
David N. Neubauer, MD
Expert Interview
New Perspectives in Insomnia: An Expert Interview With Steven G. Hull, MD
Learn about results presented at this year's APSS meeting and their implications in this interview with Steven G. Hull, MD.
Conference News
Wake Time Influences Circadian Clock More Than Bed Time 6/28/05
[Medscape Medical News]
Sleeping in causes a significantly greater shift in circadian rhythm than going to bed late, according to researchers.
REM Sleep Deprivation May Increase Sensitivity to Acute Pain 6/27/05
[Medscape Medical News]
Preliminary findings show that REM deprivation differentially produces hyperalgesia.
Oxygen Supplementation Reduces OSA-Related Psychological Distress 6/24/05
[Medscape Medical News]
Hypoxemia may play a stronger role than sleep disruption in causing psychological effects of obstructive sleep apnea.

 
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the Associated Professional Sleep Societies. These materials and the related activity are not sanctioned by the Associated Professional Sleep Societies or the commercial supporter of the conference, and do not constitute an official part of that conference.
The materials presented here do not reflect the views of Nurse Practitioner Alternatives, Medscape, or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2005 Medscape.

 


Pfizer, Inc., Neurocrine Biosciences

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.